Quick Answer
Amphastar Pharmaceuticals, Inc. reported Diluted EPS of $2.03 per share for fiscal year 2025.
Amphastar Pharmaceuticals, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.03 | -33.7% |
| 2024 | $3.06 | +17.7% |
| 2023 | $2.60 | +49.4% |
| 2022 | $1.74 | +39.2% |
| 2021 | $1.25 | +4066.7% |
| 2020 | $0.03 | -96.9% |
| 2019 | $0.98 | +916.7% |
| 2018 | -$0.12 | -250.0% |
| 2017 | $0.08 | -61.9% |
| 2016 | $0.21 | +450.0% |
| 2015 | -$0.06 | +76.0% |
| 2014 | -$0.25 | -180.6% |
| 2013 | $0.31 | -32.6% |
| 2012 | $0.46 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.37 | -52.6% | -42.2% |
| June 30, 2025 | $0.64 | -12.3% | +25.5% |
| March 31, 2025 | $0.51 | -37.0% | -34.6% |
| September 30, 2024 | $0.78 | -14.3% | +6.8% |
| June 30, 2024 | $0.73 | +49.0% | -9.9% |
| March 31, 2024 | $0.81 | +62.0% | -11.0% |
| September 30, 2023 | $0.91 | +203.3% | +85.7% |
| June 30, 2023 | $0.49 | +48.5% | -2.0% |
- Amphastar Pharmaceuticals, Inc. showed a decrease of -33.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2025 period, Amphastar Pharmaceuticals, Inc.’s diluted eps has grown by 341.3% (from $0.46 per share to $2.03 per share).
- The most recent figure is from Amphastar Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: